These findings suggested that overexpression of ACOT1 could reverse altered myocardial energy substrate use in diabetes via PPARα/PGC1α signaling, thereby ameliorating the myocardium from diabetes-induced damages. This evidence concerns the gene ACOT1 and diabetes mellitus.